Physician

Muhamad Alhaj Moustafa, M.D.

According to 2025 Medicare claims, Muhamad Moustafa, M.D. (NPI: 1023403201) practices hematology/oncology in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is MAYO CLINIC JACKSONVILLE (NPI: 1790772317; TIN: 593337028) and primary practice location at 32224-1865.

Moustafa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 710 traditional Medicare patients, billed 111,262 HCPCS/CPT codes, and received $2,063,720 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 323 prescription claims across 48 beneficiaries totaling $439,395 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 34 records totaling $588,538. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,355 to $2,063,720. Similarly, Part D prescription costs have risen steadily, from $3,151 to $439,395. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.3M2019 Medicare payment: $1,355 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $281,418 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,819,344 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,346,199 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,063,720 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191515$1,355
2020N/RN/RN/R
202118516,688$281,418
202264390,134$1,819,344
2023752121,453$2,346,199
2024710111,262$2,063,720

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$220K$439K2015 Drug cost: $3,151 (USD; Tot_Drug_Cst)2016 Drug cost: $10,510 (USD; Tot_Drug_Cst)2017 Drug cost: $40,004 (USD; Tot_Drug_Cst)2018 Drug cost: $13,848 (USD; Tot_Drug_Cst)2019 Drug cost: $7,992 (USD; Tot_Drug_Cst)2020 Drug cost: $97,441 (USD; Tot_Drug_Cst)2021 Drug cost: $113,574 (USD; Tot_Drug_Cst)2022 Drug cost: $178,579 (USD; Tot_Drug_Cst)2023 Drug cost: $282,865 (USD; Tot_Drug_Cst)2024 Drug cost: $439,395 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151555$3,151
201638223$10,510
201763251$40,004
201850201$13,848
20193685$7,992
20202583$97,441
202137119$113,574
202244305$178,579
202350350$282,865
202448323$439,395

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less239287$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more92173$88
36591Collection of blood sample from implanted device108149$20
96375Injection of additional new drug or substance into vein176514$12
J1100Injection, dexamethasone sodium phosphate, 1 mg1181,772$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib27810$386,792
EliquisApixaban22720$13,649
AcyclovirAcyclovir984,284$1,002
Ondansetron HclOndansetron Hcl12147$205
Prochlorperazine MaleateProchlorperazine Maleate20147$198

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$4,449Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.23$584,089Celgene Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muhamad Alhaj Moustafa, M.D.?

Tedicare shows public-source Medicare data for Muhamad Alhaj Moustafa, M.D. (NPI 1023403201), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhamad Alhaj Moustafa, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Muhamad Alhaj Moustafa, M.D.?

Muhamad Alhaj Moustafa, M.D. is linked to MAYO CLINIC JACKSONVILLE (billing NPI 1790772317) in the available physician profile data.

Does Muhamad Alhaj Moustafa, M.D. have Open Payments data?

Muhamad Alhaj Moustafa, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.